ACCESS FUND
Grants are available to assist eligible organisations to purchase the services of the National Biomanufacturing Centre from a £3million Access Fund, administered by the Northwest Regional Development Agency and funded by the DTI and European Regional Development Funding. NBC Services are provided on a fee–for–service basis by the NBC Operator, Eden Biodesign.
The Access Fund supports the development and early stage production of biopharmaceuticals in the UK. Applications from research organisations (HEIs, NHS Trust, Charitable bodies) and biotech companies are reviewed by an independent panel.
To find out more about the NBC Access Fund click on the brochure image.
For guidelines on completing Access Fund Applications please click here.
The NBC’s facilities are purchased on a fee–for–service basis from its operator, Eden Biodesign. To find out more about how the NBC can help you contact Dr Derek Ellison.
Applicants are also advised to contact Dr Linda Magee of Bionow at the NWDA before submission of applications to ensure that they have all the relevant information.
Important Notice:
Arrangements for Applications from December 2007
The fund was launched in 2005 and will close in 2008. To-date the fund has received applicants on an open rather than call basis but, as a significant proportion of the fund has now been allocated, the remainder of the fund will be administered and allocated in response to a single, final call. All applications submitted from November 2007 will be considered in a single review process in February 2008. The last date for application for this final review process will be January 31 2008. For further information on NBC Access Fund Final Call please click here.
